New take on depression and schizophrenia research
February 2nd, 2010
Academia and industry have joined forces to investigate and find novel methods for the development of drugs for depression and schizophrenia. the newmeds (‘novel methods leading to new medications in depression and schizophrenia’) project is funded by the innovative medicines initiative (imi), a public-private partnership between the pharmaceutical industry (represented by the european federation of pharmaceutical industries and associations (efpia)) and the eu, under the seventh framework programme (fp7). support totals eur 1 billion which will be matched in kind from the efpia member companies.
Read the full article here
